BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2650472)

  • 1. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases using calcium antagonists in an acute trial].
    Schauer J; Himmel W; Orschekowski H
    Z Gesamte Inn Med; 1989 Jan; 44(2):50-4. PubMed ID: 2650472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of nifedipine (Corinfar) on pulmonary hypertension in chronic obstructive lung disease.
    Schauer J; Orschekowski H; Steiniger L; Winkler J; Schilling W; Harzbecker K; Evers H
    Z Erkr Atmungsorgane; 1990; 175(3):132-40. PubMed ID: 2127872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A; Philip-Joet F; Guintoli A; Torresani J; Arnaud A
    Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
    Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M
    Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC; Joshi RC; Mehta R; Cunnington AR
    Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of acute and chronic nitrate administration in precapillary and postcapillary pulmonary hypertension.
    Jezková J; Jezek V; Michaljanic A; Niederle P; Fucík J
    Cor Vasa; 1991; 33(4):308-14. PubMed ID: 1743025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration].
    Liu Z; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases by trapidil (Rocornal) in an acute trial].
    Schauer J; Orschekowski H; Winkler J; Steiniger L
    Z Erkr Atmungsorgane; 1991; 177(3):204-16. PubMed ID: 1808871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies with nifedipine. Hemodynamic study over 18 months].
    Saadjian A; Philip-Joet F; Vestri R; Arnaud A
    Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):197-202. PubMed ID: 2735734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension].
    Volkova LI
    Ter Arkh; 1989; 61(8):50-3. PubMed ID: 2588166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study.
    Saadjian AY; Philip-Joet FF; Vestri R; Arnaud AG
    Eur Respir J; 1988 Aug; 1(8):716-20. PubMed ID: 3069486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease.
    Bratel T; Hedenstierna G; Nyquist O; Ripe E
    Eur J Respir Dis; 1985 Oct; 67(4):244-53. PubMed ID: 4076363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nifedipine treatment of pulmonary hypertension as a complication of chronic obstructive diseases of the lungs].
    Paleev NR; Tsa'rkova LN; Uribe-Echevarria EE; Baklykova SN; Novoderezhkina LB
    Klin Med (Mosk); 1989 Jun; 67(6):117-20. PubMed ID: 2674536
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists in heart failure.
    Klugmann S; Salvi A; Camerini F
    Herz; 1983 Apr; 8(2):88-92. PubMed ID: 6852766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nifedipine in the treatment of chronic cor pulmonale].
    Saadjian A; Philip-Joet F; Tran N'guyen A; Arnaud A; Torresani J
    Arch Mal Coeur Vaiss; 1986 Jan; 79(1):76-83. PubMed ID: 3085613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
    Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
    Gassner A
    Schweiz Med Wochenschr; 1984 Mar; 114(10):332-7. PubMed ID: 6710104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.